Board Approves Interim 2009 Dividend of 1.14 €/Share
Total: Second Quarter and First Half 2009 Results
TOTAL
Total (Paris:FP) (LSE:TTA) (NYSE:TOT):
Main results 1-2
-- Second quarter adjusted net income 3 |
 | 1.7 billion euros |  | -54% |
2.3 billion dollars | -60% | |||
0.77 euros per share | -53% | |||
1.05 dollars per share | -59% | |||
-- First half adjusted net income |
3.8 billion euros | -45% | ||
5.1 billion dollars | -52% | |||
-- First half net income (Group share) |
4.5 billion euros | -46% |
Highlights since the beginning of the second quarter 2009
The Board of Directors of Total, led by Chairman Thierry Desmarest, met on July 30, 2009 to review the Group’s second quarter and first half 2009.
Adjusted net income was 1,721 million euros (M€), a decrease of 54% compared to the second quarter 2008 and 19% compared to first quarter 2009.
The Board of Directors approved the 2009 interim dividend of 1.14 €/share for payment in November4.
Commenting on the results, CEO Christophe de Margerie said :
«In the second quarter, the price of Brent rose by 33% compared to the first quarter, lifted by the anticipation of an economic recovery and by OPEC maintaining its production discipline. However, weak demand caused natural gas prices and refining margins to fall sharply. The environment for chemicals stabilized after recent quarters that were affected by low demand. The dollar averaged 1.36 $/€ in the quarter.
Total’s adjusted net income of 2.35 billion dollars and gearing close to 25% confirms that we are able to resist in a weaker environment. Since the start of the year, Total has issued close to 5 billion euros of debt with competitive terms to maintain its financial flexibility.
While maintaining a sustained level of investment to prepare for the future, Total is fully engaged in ongoing cost reduction and optimization programs needed to lower the breakeven points and launch new development projects. For example, after succeeding in significantly reducing costs, the Group made its final investment decision on the Jubail refinery project with Saudi Aramco and awarded construction contracts.
Since the beginning of the year, the Akpo, Tahiti and Tyrihans fields have started up as planned. Despite these successes, the Group’s hydrocarbon production declined relative to the first quarter of this year because of high maintenance, impact of higher prices on entitlement production and weak gas demand with only a partial offset from the contribution from new fields.
Over the remaining months of the year, we expect to benefit from the ramp-up of these new fields and the start-up of Yemen LNG, Qatargas II train B and Tombua Landana in Angola. Exploration success during the quarter, acquisition of new permits and the partnerships with Cobalt in the Gulf of Mexico and Novatek in Russia all combine to strengthen the potential of the Group.
The recent industrial accidents regrettably confirm that the Group must maintain its efforts for vigilance and improvement of safety at the highest levels. In the framework of its policy for investment, training and management, Total will continue to give priority to the safety of its personnel and the protection of the environment.
Confident in its outlook and financial strength, Total will pay an interim dividend to its shareholders in November4 of 1.14 € per share, the same amount as the interim and final 2008 dividends. »
2Q09 | Â | 1Q09 | Â | 2Q08 | Â |
2Q09 vsvs 2Q082Q08 |
 |
in millions of euros except earnings per share and number of shares |
 | 1H09 |  | 1H08 |  |
1H09 vsvs 1H081H08 |
31,430 | 30,041 | 48,200 | -35% | Sales | 61,471 | 92,413 | -33% | |||||||
3,044 | 3,615 | 7,786 | -61% | Adjusted operating income from business segments | 6,659 | 14,905 | -55% | |||||||
1,678 | 2,050 | 3,756 | -55% | Adjusted net operating income from business segments | 3,728 | 6,956 | -46% | |||||||
1,451 | 1,482 | 3,099 | -53% | = Upstream | 2,933 | 5,830 | -50% | |||||||
156 | 600 | 587 | -73% | = Downstream | 756 | 898 | -16% | |||||||
71 | -32 | 70 | +1% | = Chemicals | 39 | 228 | -83% | |||||||
1,721 | 2,113 | 3,723 | -54% | Adjusted net income | 3,834 | 6,977 | -45% | |||||||
0.77 | 0.95 | 1.65 | -53% | Adjusted fully-diluted earnings per share (euros) | 1.72 | 3.10 | -45% | |||||||
2,235.6 | 2,235.4 | 2,252.9 | -1% | Fully-diluted weighted-average shares (millions) | 2,235.5 | 2,253.4 | -1% | |||||||
2,169 | 2,290 | 4,732 | -54% | Net income (Group share) | 4,459 | 8,334 | -46% | |||||||
3,634 | 2,935 | 2,868 | +27% |
Investments6 |
6,569 | 5,511 | +19% | |||||||
3,575 | 2,840 | 2,138 | +67% | Investments6 including net investments in equity affiliates and non-consolidated companies | 6,415 | 4,684 | +37% | |||||||
858 | 472 | 726 | +18% | Divestments | 1,330 | 924 | +44% | |||||||
1,939 | 3,994 | 1,922 | +1% | Cash flow from operations | 5,933 | 7,238 | -18% | |||||||
3,237 | 3,372 | 4,798 | -33% | Adjusted cash flow from operations | 6,609 | 9,129 | -28% |
2Q09 | Â | 1Q09 | Â | 2Q08 | Â |
2Q09 vsvs 2Q082Q08 |
 |
in millions of dollars 7 |
 | 1H09 |  | 1H08 |  |
1H09 vsvs 1H081H08 |
42,845 | 39,140 | 75,298 | -43% | Sales | 81,929 | 141,429 | -42% | |||||||
4,150 | 4,710 | 12,163 | -66% | Adjusted operating income from business segments | 8,875 | 22,811 | -61% | |||||||
2,287 | 2,671 | 5,868 | -61% | Adjusted net operating income from business segments | 4,969 | 10,645 | -53% | |||||||
1,978 | 1,931 | 4,841 | -59% | = Upstream | 3,909 | 8,922 | -56% | |||||||
213 | 782 | 917 | -77% | = Downstream | 1,008 | 1,374 | -27% | |||||||
97 | -42 | 109 | -11% | = Chemicals | 52 | 349 | -85% | |||||||
2,346 | 2,753 | 5,816 | -60% | Adjusted net income | 5,110 | 10,678 | -52% | |||||||
1.05 | 1.23 | 2.58 | -59% | Adjusted fully-diluted earnings per share (dollars) | 2.29 | 4.74 | -52% | |||||||
2,235.6 | 2,235.4 | 2,252.9 | -1% | Fully-diluted weighted-average shares (millions) | 2,235.5 | 2,253.4 | -1% | |||||||
2,957 | 2,984 | 7,392 | -60% | Net income (Group share) | 5,943 | 12,754 | -53% | |||||||
4,954 | 3,824 | 4,480 | +11% | Investments6 | 8,755 | 8,434 | +4% | |||||||
4,873 | 3,700 | 3,340 | +46% | Investments6 including net investments in equity affiliates and non-consolidated companies | 8,550 | 7,168 | +19% | |||||||
1,170 | 615 | 1,134 | +3% | Divestments | 1,773 | 1,414 | +25% | |||||||
2,643 | 5,204 | 3,003 | -12% | Cash flow from operations | 7,908 | 11,077 | -29% | |||||||
4,413 | 4,393 | 7,495 | -41% | Adjusted cash flow from operations | 8,808 | 13,971 | -37% |
- Operating income
In the second quarter 2009, the Brent price averaged 59.1 $/b, a decrease of 51% compared to the second quarter 2008 and an increase of 33% compared to the first quarter 2009. The TRCV European refining margin indicator fell to 12.4 $/t on average in the second quarter 2009, a decrease of 69% compared to the second quarter 2008 and 64% compared to the first quarter 2009.
The euro-dollar exchange rate averaged 1.36 $/€ in the second quarter 2009 compared to 1.56 $/€ in the second quarter 2008 and 1.30 $/€ in the first quarter 2009.
In this environment, the adjusted operating income from the business segments was 3,044 M€, a decrease of 61% compared to the second quarter 20088. Expressed in dollars, the decrease was 66%.
The effective tax rate9 for the business segments was 56% in the second quarter 2009 compared to 58% in the second quarter 2008.
Adjusted net operating income from the business segments was 1,678 M€ compared to 3,756 M€ in the second quarter 2008, a decrease of 55%. The smaller decrease, relative to the one in adjusted operating income, is essentially due to a more limited decrease in the contribution from equity affiliates.
Expressed in dollars, adjusted net operating income from the business segments was 2.3Â billion dollars (B$), a decrease of 61% compared to the second quarter 2008.
- Net income
Adjusted net income was 1,721 M€ compared to 3,723 M€ in the second quarter 2008, a decrease of 54%. Expressed in dollars, adjusted net income decreased by 60%. It excludes the after-tax inventory effect, special items, and the Group’s equity share of adjustments and selected items related to Sanofi-Aventis.
Reported net income (Group share) was 2,169 M€ compared to 4,732 M€ in the second quarter 2008.
The effective tax rate for the Group was 56% in the second quarter 2009.
The Group did not buy back shares in the second quarter 2009.
Adjusted fully-diluted earnings per share, based on 2,235.6 million fully-diluted weighted-average shares, was 0.77 euros compared to 1.65 euros in the second quarter 2008, a decrease of 53%.
Expressed in dollars, adjusted fully-diluted earnings per share fell by 59% to $1.05.
- Investments – divestments11
Investments excluding acquisitions and including net investments in equity affiliates and non-consolidated companies, were 3.1 B€ (4.2 B$) in the second quarter 2009 compared to 2.1 B€ (3.3 B$) in the second quarter 2008.
Acquisitions were 480 M€ in the second quarter 2009.
Asset sales in the second quarter 2009 were 781 M€, consisting essentially of Sanofi-Aventis shares.
Net investments 12 were 2.8 B€ (3.8 B$) in the second quarter 2009 compared to 2.1 B€ (3.3 B$) in the second quarter 2008.
- Cash flow
Cash flow from operating activities was 1,939 M€ in the second quarter 2009, stable compared to the second quarter 2008, mainly due to the offsetting effects of the decrease in net income, which was linked essentially to the drop in hydrocarbon prices between the two periods, and the change in working capital.
Adjusted cash flow13 was 3,237 M€, a decrease of 33% compared to second quarter 2008. Expressed in dollars, adjusted cash flow was 4.4 B$, a decrease of 41%.
Net cash flow14 for the Group was a negative of 837 M€ compared to a negative 220 M€ in the second quarter 2008. Expressed in dollars, net cash flow for the Group was a negative 1.1 B$ in the second quarter 2009.
- Operating income
Compared to the first half 2008, the first half 2009 oil environment was marked by a 53% fall in the price of Brent to 51.7 $/b. The TRCV European refining margin indicator decreased by 27% to 23.5 $/t. The environment for Total’s petrochemicals was unfavorable, mainly as a result of weak demand in the Atlantic basin.
The euro-dollar exchange rate was 1.33 $/€ compared to 1.53 $/€ in the first half 2008.
In this context, the adjusted operating income from the business segments was 6,659 M€, a decrease of 55% compared to the first half 200815.
The effective tax rate for the business segments was 54% in the first half 2009 compared to 59% in the first half 2008, reflecting mainly the lower tax rate in the Upstream.
Adjusted net operating income from the business segments was 3,728 M€ compared to 6,956 M€ in the first half 2008, a decrease of 46%. The smaller decrease, relative to the one in adjusted operating income, is essentially due to the lower effective tax rate between the two periods and a more limited decrease in the contribution from equity affiliates.
Expressed in dollars, adjusted net operating income from the business segments fell by 53%.
- Net income
Adjusted net income decreased by 45% to 3,834 M€ in the first half 2009 from 6,977 M€ in the first half 2008. It excludes the after-tax inventory effect, special items, and the Group’s equity share of adjustments and selected items related to Sanofi-Aventis.
Reported net income (Group share) was 4,459 M€ compared to 8,334 M€ in the first half 2008.
The Group did not buy back shares in the first half 2009. On June 30, 2009, there were 2,235.5 million fully-diluted shares compared to 2,252.5 million on June 30, 2008.
Adjusted fully-diluted earnings per share, based on 2,235.5 million weighted-average shares was 1.72 euros compared to 3.10 euros in the first half 2008, a decrease of 45%.
Expressed in dollars, adjusted fully-diluted earnings per share was 2.29 compared to 4.74 in the first half 2008, a decrease of 52%.
- Investments – divestments17
Investments excluding acquisitions and including net investments in equity affiliates and non-consolidated companies, were 5.8 B€ (7.8 B$) in the first half 2009 compared to 4.6 B€ (7.0 B$) in the first half 2008.
Acquisitions were 573 M€ in the first half 2009.
Asset sales in the first half 2009 were 1,140 M€, consisting essentially of Sanofi-Aventis shares.
Net investments 18 were 7.0 B$ in the first half 2009, equal to the first half 2008.
- Cash flow
Cash flow from operating activities was 5,933 M€, a decrease of 18% compared to the first half 2008.
Adjusted cash flow19 was 6,609 M€, a decrease of 28%. Expressed in dollars, adjusted cash flow was 8.8 B$, a decrease of 37%.
Net cash flow20 for the Group was 694 M€ compared to 2,651 M€ in the first half 2008. Expressed in dollars, net cash flow for the Group was 0.9 B$ in the first half 2009.
The net-debt-to-equity ratio was 24.7% on June 30, 2009 compared to 19.1% on March 31, 2009 and 25.1% on June 30, 200821, in line with the objectives of the Group.
Upstream
- Environment – liquids and gas price realizations *
2Q09 | Â | 1Q09 | Â | 2Q08 | Â |
2Q09 vsvs 2Q082Q08 |
 |  |  | 1H09 |  | 1H08 |  |
1H09 vsvs 1H081H08 |
59.1 | 44.5 | 121.2 | -51% | Brent ($/b) | 51.7 | 109.0 | -53% | |||||||
54.8 | 41.5 | 114.9 | -52% | Average liquids price ($/b) | 48.2 | 102.8 | -53% | |||||||
4.71 | 5.98 | 7.29 | -35% | Average gas price ($/Mbtu) | 5.36 | 6.97 | -23% | |||||||
44.2 | 38.8 | 87.3 | -49% | Average hydrocarbons price ($/boe) | 41.5 | 78.8 | -47% |
* consolidated subsidiaries, excluding fixed margin and buy-back contracts.
Total’s average realized liquids price decreased by 52% and 53%, respectively, in the second quarter and the first half 2009 compared to the same periods in 2008, in line with the changes in the price of Brent.
The average realized price for Total’s natural gas decreased by 35% in the second quarter 2009 compared to the second quarter 2008 and by 23% in the first half 2009 compared to the first half 2008.
- Production
2Q09 | Â | 1Q09 | Â | 2Q08 | Â |
2Q09 vsvs 2Q082Q08 |
 | Hydrocarbon production |  | 1H09 |  | 1H08 |  |
1H09 vsvs 1H081H08 |
2,182 | 2,322 | 2,353 | -7% | Combined production (kboe/d) | 2,252 | 2,389 | -6% | |||||||
1,328 | 1,413 | 1,471 | -10% | = Liquids (kb/d) | 1,370 | 1,491 | -8% | |||||||
4,686 | 4,957 | 4,772 | -2% | = Gas (Mcf/d) | 4,821 | 4,880 | -1% |
Hydrocarbon production was 2,182 thousand barrels of oil equivalent per day (kboe/d) in the second quarter 2009, a decrease of 7.3% compared to the second quarter 2008, mainly as a result of :
In the first half 2009, hydrocarbon production was 2,252 kboe/d, a decrease of 5.7% compared to the first half 2008, mainly as a result of :
The contribution from ramp-ups and start-ups of new fields was offset by the natural decline on existing fields.
- Results
2Q09 | Â | 1Q09 | Â | 2Q08 | Â |
2Q09 vsvs 2Q082Q08 |
 | in millions of euros |  | 1H09 |  | 1H08 |  |
1H09 vsvs 1H081H08 |
2,843 | 2,892 | 6,964 | -59% | Adjusted operating income* | 5,735 | 13,387 | -57% | |||||||
1,451 | 1,482 | 3,099 | -53% | Adjusted net operating income* | 2,933 | 5,830 | -50% | |||||||
176 | 227 | 317 | -44% |
|
403 | 599 | -33% | |||||||
2,664 | 2,250 | 2,076 | +28% | Investments | 4,914 | 4,254 | +16% | |||||||
105 | 129 | 565 | -81% | Divestments | 234 | 672 | -65% | |||||||
1,943 | 2,578 | 3,643 | -47% | Cash flow from operating activities | 4,521 | 7,894 | -43% | |||||||
2,550 | 2,679 | 3,904 | -35% | Adjusted cash flow | 5,229 | 7,749 | -33% |
* detail of adjustment items shown in business segment information.
Adjusted net operating income for the Upstream segment was 1,451 M€ in the second quarter 2009 compared to 3,099 M€ in the second quarter 2008, a decrease of 53%.
Expressed in dollars, adjusted net operating income for the Upstream segment decreased by 59%, reflecting essentially the impact of lower hydrocarbon prices compared to the second quarter 2008 when Brent peaked at an average of 121 $/b.
Adjusted net operating income expressed in dollars (1,978 M$) was slightly higher compared to the first quarter 2009, mainly because the higher liquids price offset the lower gas price and lower production volumes.
Compared to the second quarter 2008, the decrease in income from equity affiliates was driven in particular by lower results from Nigeria LNG.
The effective tax rate for the Upstream segment was 58%, unchanged from the first quarter 2009. The effective tax rate for the Upstream segment was 61% in the second quarter 2008.
Adjusted net operating income for the Upstream segment in the first half 2009 was 2,933 M€ compared to 5,830 M€ in the first half 2008, a decrease of 50%.
Expressed in dollars, adjusted net operating income for the Upstream segment fell to 3.9Â B$, a decrease of 56%, essentially due to lower hydrocarbon prices.
The return on average capital employed (ROACE 23) for the Upstream segment for the twelve months ended June 30, 2009 was 25% compared to 31% for the twelve months ended March 31, 2009 and 36% for the full year 2008.
Downstream
- Refinery throughput and utilization rates *
2Q09 | Â | 1Q09 | Â | 2Q08 | Â |
2Q09 vsvs 2Q082Q08 |
 |  |  | 1H09 |  | 1H08 |  |
1H09 vsvs 1H081H08 |
2,175 | 2,236 | 2,297 | -5% | Total refinery throughput (kb/d) | 2,205 | 2,341 | -6% | |||||||
925 | 895 | 932 | -1% | = France | 910 | 931 | -2% | |||||||
1,024 | 1,086 | 1,055 | -3% | = Rest of Europe | 1,055 | 1,111 | -5% | |||||||
226 | 255 | 310 | -27% | = Rest of world | 240 | 299 | -20% | |||||||
Utilization rates | ||||||||||||||
79% | 81% | 85% | = Based on crude only | 80% | 86% | |||||||||
84% | 86% | 88% | Â | = Based on crude and other feedstock | 85% | 90% | Â |
* includes share of CEPSA.
In the second quarter 2009, refinery throughput decreased by 5% compared to the second quarter 2008 and by 3% compared to the first quarter 2009.
The second quarter 2009 was affected by the completion of scheduled refinery turnarounds at Donges and Antwerp as well as scheduled turnarounds initiated at Lindsey and Vlissingen. Also, due to the economic conditions, certain refineries elected to reduce throughput during the quarter.
In the second quarter 2008, there was a scheduled turnaround at Leuna and partial turnarounds at Normandy and Grandpuits. In the first quarter 2009, there were scheduled turnarounds at Donges and Lindsey in addition to a voluntary throughput reduction at the Port Arthur refinery in March.
Increased turnarounds and voluntary throughput reductions in the second quarter 2009 reduced the utilization rate based on crude and other feedstocks to 84% from 88% in the second quarter 2008 and 86% in the first quarter 2009.
- Results
2Q09 | Â | 1Q09 | Â | 2Q08 | Â |
2Q09 vsvs 2Q082Q08 |
 |
in millions of euros except TRCV refining marginsexcept TRCV refining margins |
 | 1H09 |  | 1H08 |  | 1H09 vs 1H08 |
12.4 | 34.7 | 40.2 | -69% |
European refining margin
indicator - TRCV ($/t) |
23.5 | 32.4 | -27% | |||||||
 |  |  |  |  |  |  |  | |||||||
141 | 791 | 744 | -81% | Adjusted operating income * | 932 | 1,242 | -25% | |||||||
156 | 600 | 587 | -73% | Adjusted net operating income * | 756 | 898 | -16% | |||||||
28 | 33 | 15 | +87% |
|
61 | 17 | x4 | |||||||
 |  |  |  |  |  |  |  | |||||||
825 | 495 | 514 | +61% | Investments | 1,320 | 808 | +63% | |||||||
26 | 36 | 128 | -80% | Divestments | 62 | 152 | -59% | |||||||
(28) | 1,648 | (1,391) | na | Cash flow from operating activities | 1,620 | (223) | na | |||||||
239 | 934 | 623 | -62% | Adjusted cash flow | 1,173 | 1,143 | +3% |
* detail of adjustment items shown in business segment information.
The TRCV European refining margin indicator averaged 12.4 $/t in the second quarter 2009, a decrease of 69% compared to the second quarter 2008 and a decrease of 64% compared to the first quarter 2009. Gasoline margins declined by less than diesel margins, but refining margins as a group suffered over the quarter.
Adjusted net operating income for the Downstream segment was 156 M€ in the second quarter 2009, a decrease of 73% compared to the second quarter 2008 and 74% compared to the first quarter 2009.
Expressed in dollars, adjusted net operating income for the Downstream segment was 213Â M$, a decrease of 77% compared to the second quarter 2008 and 73% compared to the first quarter 2009, mainly due to the sharp decline of refining margins and to conditions for supply optimization that were particularly favorable in the first quarter 2009.
Adjusted net operating income for the Downstream segment in the first half 2009 was 756 M€, a decrease of 16% compared to the first half 2008.
Expressed in dollars, adjusted net operating income for the Downstream segment was 1Â B$ in the first half 2009, a decrease of 27% compared to the first half 2008, reflecting essentially the less favorable refining environment.
The ROACE24 for the Downstream segment for the twelve months ended June 30, 2009 was 18% compared to 23% for the twelve months ended March 31, 2009 and 20% for the full year 2008.
Chemicals
2Q09 | Â | 1Q09 | Â | 2Q08 | Â |
2Q09 vsvs 2Q082Q08 |
 | in millions of euros |  | 1H09 |  | 1H08 |  | 1H09 vs 1H08 |
3,684 | 3,218 | 5,478 | -33% | Sales | 6,902 | 10,707 | -36% | |||||||
2,164 | 1,776 | 3,632 | -40% | = Base chemicals | 3,940 | 7,052 | -44% | |||||||
1,520 | 1,442 | 1,846 | -18% | = Specialties | 2,962 | 3,655 | -19% | |||||||
 |  |  |  |  |  |  |  | |||||||
60 | (68) | 78 | -23% | Adjusted operating income * | (8) | 276 | na | |||||||
71 | (32) | 70 | +1% | Adjusted net operating income * | 39 | 228 | -83% | |||||||
19 | (40) | (23) | na |
|
(20) | 38 | na | |||||||
58 | 16 | 97 | -40% |
|
74 | 195 | -62% | |||||||
 |  |  |  |  |  |  |  | |||||||
115 | 179 | 221 | -48% | Investments | 294 | 385 | -24% | |||||||
8 | 6 | 12 | -33% | Divestments | 14 | 19 | -26% | |||||||
280 | 178 | 169 | +66% | Cash flow from operating activities | 458 | (33) | na | |||||||
114 | (134) | 152 | -25% | Adjusted cash flow | (20) | 418 | na |
* detail of adjustment items shown in business segment information.
In the second quarter 2009, petrochemical margins remained under pressure from weak demand in the Atlantic basin and, in the second half of the quarter, suffered from rising naphtha prices. The utilization rate for petrochemical units, however, increased from the low levels of the previous quarter.
In the second quarter 2009, sales for the Chemicals segment were 3.7 B€.
Adjusted net operating income for the Chemicals segment was 71 M€, stable compared to the second quarter 2008 and an increase of more than 100 M€ compared to the first quarter 2009.
Compared to the first quarter 2009, the improvement in the Chemicals results were mainly due to relatively good petrochemical export sales to Asia and better resistance by the Specialties that reflected, in particular, their cost reduction efforts and a slight improvement in Asian demand.
In the first half 2009, adjusted net operating income for the Chemicals segment was 39 M€ compared to 228 M€ in the first half 2008, a decrease of 83% that resulted from the economic recession, particularly as it affected Europe and North America.
The ROACE25 for the Chemicals segment for the twelve months ended June 30, 2009 was 7% compared to 7% for the twelve months ended March 31, 2009 and 9% for the full year 2008.
At the July 30, 2009 meeting, the Board of Directors approved the cancellation of 24,800,000 shares bought in 2008, adjusting the share capital to 5,867,520,185 € based on 2,347,008,074 shares with a par value of 2.5 € per share.
Net income for TOTAL S.A., the parent company, was 3,240 M€ in the first half of 2009 compared to 3,083 M€ in the first half of 2008.
The ROACE for the twelve months ended June 30, 2009 was 19% for the Group and 21% for the business segments compared respectively to 24% and 26% for the twelve months ended March 31, 2009 and 26% and 28% for the full year 2008.
Return on equity for the twelve months ended June 30, 2009 was 23%.
Total will pay the 2009 interim dividend of 1.14 € per share on November 18, 200926.
The Group maintains its net-debt-to-equity ratio objective of 25-30% for year-end 2009.
Since the start of the third quarter 2009, oil prices have remained above the average of the first six months. European refining margins are currently at very weak levels. Chemicals are continuing to suffer the effects of reduced demand in the Atlantic basin, but there are positive signs for demand in Asia.
The coming months should be marked by production ramp-ups at the Akpo field in Nigeria, Tahiti in the Gulf of Mexico, Tyrihans in Norway as well as the start-up of Yemen LNG in the third quarter then Qatargas II train B and Tombua Landana in Angola by the end of the year.
To listen to CFO Patrick de la Chevardière’s conference call with financial analysts today at 15:00 (Paris time) please log on to www.total.com or call +44 (0)203 147 4744 in Europe or +1 866 907 5924 in the U.S. (access code : Total). For a replay, please consult the website or call +44 (0)207 107 0686 in Europe or 1 866 794 2598 in the US (code : 253 101).
This document does not constitute the Financial Report for the first half 2009 which will be separately published, in accordance with article L.451-1-2 III of the French Code monétaire et financier, and is available on our web site www.total.com or upon request at the company’s headquarters.
The June 30, 2009 notes to the condensed consolidated accounts are available on the Total web site (www.total.com). This document may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to the financial condition, results of operations, business, strategy and plans of Total. Such statements are based on a number of assumptions that could ultimately prove inaccurate, and are subject to a number of risk factors, including currency fluctuations, the price of petroleum products, the ability to realize cost reductions and operating efficiencies without unduly disrupting business operations, environmental regulatory considerations and general economic and business conditions. Total does not assume any obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Further information on factors which could affect the company’s financial results is provided in documents filed by the Group and its affiliates with the French Autorité des Marchés Financiers and the US Securities and Exchange Commission.
Business segment information is presented in accordance with the Group internal reporting system used by the Chief operating decision maker to measure performance and allocate resources internally. Due to their particular nature or significance, certain transactions qualified as “special items†are excluded from the business segment figures. In general, special items relate to transactions that are significant, infrequent or unusual. However, in certain instances, certain transactions such as restructuring costs or assets disposals, which are not considered to be representative of normal course of business, may be qualified as special items although they may have occurred within prior years or are likely to recur within following years.
The adjusted results of the Downstream and Chemical segments are also presented according to the replacement cost method. This method is used to assess the segments’ performance and ensure the comparability of the segments’ results with those of its competitors, mainly North American.
In the replacement cost method, which approximates the LIFO (Last-In, First-Out) method, the variation of inventory values in the income statement is determined by the average price of the period rather than the historical value. The inventory valuation effect is the difference between the results according to FIFO (First-In, First-Out) and replacement cost.
In this framework, performance measures such as adjusted operating income, adjusted net operating income and adjusted net income are defined as incomes using replacement cost, adjusted for special items and excluding Total’s equity share of the adjustments and, from 2009, selected items related to Sanofi-Aventis. They are meant to facilitate the analysis of the financial performance and the comparison of income between periods.
Dollar amounts presented herein represent euro amounts converted at the average euro-dollar exchange rate for the applicable period and are not the result of financial statements prepared in dollars.
Operating information by segment
Second quarter and first half 2009
2Q09 | Â | 1Q09 | Â | 2Q08 | Â | 2Q09 vs 2Q08 | Â | Combined liquids and gas production by region (kboe/d) | Â | 1H09 | Â | 1H08 | Â | 1H09 vs 1H08 |
574 | 686 | 601 | -4% | Europe | 629 | 614 | +2% | |||||||
713 | 741 | 789* | -10% | Africa | 728 | 819* | -11% | |||||||
13 | 11 | 14 | -7% | North America | 12 | 15 | -20% | |||||||
248 | 255 | 246 | +1% | Far East | 251 | 249 | +1% | |||||||
420 | 419 | 433 | -3% | Middle East | 419 | 435 | -4% | |||||||
193 | 184 | 244* | -21% | South America | 189 | 230* | -18% | |||||||
21 | 26 | 26* | -19% | Rest of world | 24 | 27* | -11% | |||||||
2,182 | 2,322 | 2,353 | -7% | Total production | 2,252 | 2,389 | -6% | |||||||
342 | 350 | 418 | -18% | Includes equity and non-consolidated affiliates | 346 | 407 | -15% |
* restated to reclassify Total’s 48.83% share of CEPSA’s production in Colombia
2Q09 | Â | 1Q09 | Â | 2Q08 | Â | 2Q09 vs 2Q08 | Â | Liquids production by region (kb/d) | Â | 1H09 | Â | 1H08 | Â | 1H09 vs 1H08 |
275 | 320 | 299 | -8% | Europe | 297 | 299 | -1% | |||||||
600 | 633 | 657* | -9% | Africa | 618 | 687* | -10% | |||||||
11 | 10 | 11 | - | North America | 10 | 11 | -9% | |||||||
33 | 36 | 27 | +22% | Far East | 34 | 27 | +26% | |||||||
310 | 315 | 331 | -6% | Middle East | 312 | 333 | -6% | |||||||
87 | 85 | 134* | -35% | South America | 86 | 122* | -30% | |||||||
12 | 14 | 12* | - | Rest of world | 13 | 12* | +8% | |||||||
1,328 | 1,413 | 1,471 | -10% | Total production | 1,370 | 1,491 | -8% | |||||||
289 | 294 | 366 | -21% | Includes equity and non-consolidated affiliates | 291 | 353 | -18% |
* restated to reclassify Total’s 48.83% share of CEPSA’s production in Colombia
2Q09 | Â | 1Q09 | Â | 2Q08 | Â | 2Q09 vs 2Q08 | Â | Gas production by region (Mcf/d) | Â | 1H09 | Â | 1H08 | Â | 1H09 vs 1H08 |
1,639 | 1,985 | 1,639 | - | Europe | 1,811 | 1,707 | +6% | |||||||
580 | 551 | 667 | -13% | Africa | 566 | 678 | -17% | |||||||
9 | 8 | 19 | -53% | North America | 9 | 21 | -57% | |||||||
1,215 | 1,223 | 1,210 | - | Far East | 1,219 | 1,228 | -1% | |||||||
609 | 574 | 548 | +11% | Middle East | 591 | 564 | +5% | |||||||
585 | 549 | 610 | -4% | South America | 567 | 600 | -5% | |||||||
49 | 67 | 79 | -38% | Rest of world | 58 | 82 | -29% | |||||||
4,686 | 4,957 | 4,772 | -2% | Total production | 4,821 | 4,880 | -1% | |||||||
285 | 302 | 281 | +1% | Includes equity and non-consolidated affiliates | 293 | 294 | - |
2Q09 | Â | 1Q09 | Â | 2Q08 | Â | 2Q09 vs 2Q08 | Â | Liquefied natural gas | Â | 1H09 | Â | 1H08 | Â | 1H09 vs 1H08 |
2.12 | 2.10 | 2.16 | -2% | LNG sales* (Mt) | 4.22 | 4.48 | -6% |
* sales, Group share, excluding trading ; 1 Mt/y = approx. 133 Mcf/d ; data from 2008 previous period have been restated to reflect volumes estimation for Bontang LNG in Indonesia based on the 2008 SEC coefficient
2Q09 | Â | 1Q09 | Â | 2Q08 | Â | 2Q09 vs 2Q08 | Â | Refined products sales by region (kb/d)* | Â | 1H09 | Â | 1H08 | Â | 1H09 vs 1H08 |
1,979 | 2,176 | 1,999 | -1% | Europe | 2,076 | 2,071 | - | |||||||
272 | 277 | 280 | -3% | Africa | 275 | 280 | -2% | |||||||
161 | 189 | 220 | -27% | Americas | 175 | 188 | -7% | |||||||
148 | 128 | 143 | +3% | Rest of world | 138 | 144 | -4% | |||||||
2,560 | 2,770 | 2,642 | -3% | Total consolidated sales | 2,664 | 2,683 | -1% | |||||||
1,092 | 1,000 | 956 | +14% | Trading | 1,046 | 950 | +10% | |||||||
 |  |  |  |  |  |  |  | |||||||
3,652 | 3,770 | 3,598 | +2% | Total refined product sales | 3,710 | 3,633 | +2% |
* includes share of CEPSA
Adjustment items
2Q09 | Â | 1Q09 | Â | 2Q08 | Â | in millions of euros | Â | 1H09 | Â | 1H08 |
(188) | (103) | - | Special items affecting operating income from the business segments | (291) | - | |||||
- | - | - | = Restructuring charges | - | - | |||||
(105) | - | - | = Impairments | (105) | - | |||||
(83) | (103) | - | = Other | (186) | - | |||||
1,065 | 477 | 1,687 | Pre-tax inventory effect : FIFO vs. replacement cost | 1,542 | 2,062 | |||||
 |  |  |  |  |  | |||||
877 | 374 | 1,687 | Total adjustments affecting operating income from the business segments | 1,251 | 2,062 |
2Q09 | Â | 1Q09 | Â | 2Q08 | Â | in millions of euros | Â | 1H09 | Â | 1H08 |
(221) | (87) | (67) | Special items affecting net income (Group share) | (308) | 78 | |||||
28 | 13 | 2 | = Gain on asset sales | 41 | 147 | |||||
(99) | (6) | (44) | = Restructuring charges | (105) | (44) | |||||
(71) | - | - | = Impairments | (71) | - | |||||
(79) | (94) | (25) | = Other | (173) | (25) | |||||
(119) | (63) | (78) | Equity shares of adjustments and, from 2009, selected items related to Sanofi-Aventis* | (182) | (149) | |||||
788 | 327 | 1,154 | After-tax inventory effect : FIFO vs. replacement cost | 1,115 | 1,428 | |||||
 |  |  |  |  |  | |||||
448 | 177 | 1,009 | Total adjustments to net income | 625 | 1,357 |
* based on Total’s share in Sanofi-Aventis of 9.7% at 6/30/2009, 10.9% at 3/31/2009 and 13% at 6/30/2008
Effective tax rates
2Q09 | Â | 1Q09 | Â | 2Q08 | Â | Effective tax rate * | Â | 1H09 | Â | 1H08 |
58.3% | 58.1% | 61.2% | Upstream | 58.2% | 61.8% | |||||
55.9% | 52.2% | 57.8% | Group | 53.9% | 58.6% |
* tax on adjusted net operating income / (adjusted net operating income - income from equity affiliates, dividends received from investments, and impairments of acquisition goodwill + tax on adjusted net operating income).
Investments - Divestments
2Q09 | Â | 1Q09 | Â | 2Q08 | Â | 2Q09 vs 2Q08 | Â | in millions of euros | Â | 1H09 | Â | 1H08 | Â | 1H09 vs 1H08 |
3,095 | 2,747 | 2,091 | +48% | Investments* excluding acquisitions | 5,842 | 4,589 | +27% | |||||||
154 | 228 | 205 | -25% |
|
382 | 377 | +1% | |||||||
23 | 225 | (522) | na |
|
248 | (410) | na | |||||||
480 | 93 | 47 | x10 | Acquisitions | 573 | 95 | x6 | |||||||
3,575 | 2,840 | 2,138 | +67% | Investments* including acquisitions | 6,415 | 4,684 | +37% | |||||||
781 | 359 | 120 | x7 | Asset sales | 1,140 | 195 | x6 | |||||||
2,776 | 2,463 | 2,142 | +30% | Net investments ** | 5,239 | 4,587 | +14% |
2Q09 | Â | 1Q09 | Â | 2Q08 | Â | 2Q09 vs 2Q08 | Â | in millions of dollars*** | Â | 1H09 | Â | 1H08 | Â | 1H09 vs 1H08 |
4,219 | 3,579 | 3,267 | +29% | Investments* excluding acquisitions | 7,786 | 7,023 | +11% | |||||||
210 | 297 | 320 | -34% |
|
509 | 577 | -12% | |||||||
31 | 293 | (815) | na |
|
331 | (627) | na | |||||||
654 | 121 | 73 | x9 | Acquisitions | 764 | 145 | x5 | |||||||
4,873 | 3,700 | 3,340 | +46% | Investments* including acquisitions | 8,550 | 7,168 | +19% | |||||||
1,065 | 468 | 187 | x6 | Asset sales | 1,519 | 298 | x5 | |||||||
3,784 | 3,209 | 3,346 | +13% | Net investments ** | 6,983 | 7,020 | -1% |
* includes net investments in equity affiliates and non-consolidated companies.
** net investments = investments including acquisitions and net investments in equity affiliates and non-consolidated companies – asset sales + net financing for employees related to stock purchase plans.
*** dollar amounts represent euro amounts converted at the average €-$ exchange rate for the period
Net-debt-to-equity ratio
in millions of euros | Â | 6/30/2009 | Â | 3/31/2009 | Â | 6/30/2008 |
Current borrowings | 7,916 | 4,771 | 4,795 | |||
Net current financial assets | (123) | (80) | (49) | |||
Non-current financial debt | 19,640 | 19,078 | 14,777 | |||
Hedging instruments of non-current debt | (875) | (934) | (540) | |||
Cash and cash equivalents | (14,299) | (13,319) | (7,245) | |||
Net debt | 12,259 | 9,516 | 11,738 | |||
 |  |  |  | |||
Shareholders equity | 51,299 | 52,597 | 48,273 | |||
Estimated dividend payable* | (2,541) | (3,812) | (2,315) | |||
Minority interests | 963 | 1,004 | 855 | |||
Equity | 49,721 | 49,789 | 46,813 | |||
 |  |  |  | |||
Net-debt-to-equity ratio | 24.7% | 19.1% | 25.1% |
* June 30, 2009 based on the hypothesis of an annual dividend of 2.28 €/share
2009 Sensitivities*
 |  | Scenario |  | Change |  | Impact on adjusted operating income(e) |  | Impact on adjusted net operating income(e) |
Dollar | 1.30 $/€ | +0.1 $ per € | -1.3 B€ | -0.7 B€ | ||||
Brent | 60 $/b | +1 $/b | +0.32 B€ / 0.42 B$ | +0.15 B€ / 0.20 B$ | ||||
European refining margins TRCV | 30 $/t | +1 $/t | +0.08 B€ / 0.11 B$ | +0.06 B€ / 0.07 B$ |
* sensitivities revised once per year upon publication of the previous year’s fourth quarter results. The impact of the €-$ sensitivity on adjusted operating income and adjusted net operating income attributable to the Upstream segment are approximately 75% and 65% respectively, and the remaining impact of the €-$ sensitivity is essentially in the Downstream segment.
Return on average capital employed
in millions of euros | Â | Upstream | Â | Downstream | Â | Chemicals** | Â | Segments | Â | Â | Â | Group |
Adjusted net operating income | 7,827 | 2,427 | 479 | 10,733 | 11,388 | |||||||
Capital employed at 6/30/2008* | 26,676 | 13,491 | 7,394 | 47,561 | 56,107 | |||||||
Capital employed at 6/30/2009* | 35,385 | 13,939 | 6,915 | 56,239 | 62,294 | |||||||
ROACE | 25.2% | 17.7% | 6.7% | 20.7% | 19.2% |
* at replacement cost (excluding after-tax inventory effect).
** capital employed for Chemicals reduced for the Toulouse-AZF provision of 126 M€ pre-tax at 6/30/2008
in millions of euros | Â | Upstream | Â | Downstream | Â | Chemicals** | Â | Segments | Â | Â | Â | Group |
Adjusted net operating income | 9,475 | 2,858 | 478 | 12,811 | 13,462 | |||||||
Capital employed at 3/31/2008* | 25,731 | 11,415 | 7,266 | 44,412 | 52,015 | |||||||
Capital employed at 3/31/2009* | 35,027 | 13,095 | 7,175 | 55,297 | 61,688 | |||||||
ROACE | 31.2% | 23.3% | 6.6% | 25.7% | 23.7% |
* at replacement cost (excluding after-tax inventory effect).
** capital employed for Chemicals reduced for the Toulouse-AZF provision of 129 M€ pre-tax at 3/31/2008
in millions of euros | Â | Upstream | Â | Downstream | Â | Chemicals** | Â | Segments | Â | Â | Â | Group |
Adjusted net operating income | 10,724 | 2,569 | 668 | 13,961 | 14,664 | |||||||
Capital employed at 12/31/2007* | 27,062 | 12,190 | 7,033 | 46,285 | 54,158 | |||||||
Capital employed at 12/31/2008* | 32,681 | 13,623 | 7,417 | 53,721 | 59,764 | |||||||
ROACE | 35.9% | 19.9% | 9.2% | 27.9% | 25.7% |
* at replacement cost (excluding after-tax inventory effect).
** capital employed for Chemicals reduced for the Toulouse-AZF provision of 134 M€ pre-tax at 12/31/2007 and 256 M€ pre-tax at 12/31/2008
Total Financial statements
Second quarter and first half 2009 consolidated accounts, IFRS
CONSOLIDATED STATEMENT OF INCOME | Â | Â | Â | |||
TOTAL | ||||||
(unaudited) | ||||||
 | ||||||
(M€) (a) |
2nd quarter
2009 |
1st quarter
2009 |
2nd quarter
2008 |
|||
Sales | 31,430 | 30,041 | 48,200 | |||
Excise taxes | (4,856) | (4,573) | (4,900) | |||
Revenues from sales | 26,574 | 25,468 | 43,300 | |||
Purchases, net of inventory variation | (16,300) | (15,228) | (27,958) | |||
Other operating expenses | (4,724) | (4,675) | (4,439) | |||
Exploration costs | (155) | (176) | (203) | |||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,636) | (1,520) | (1,384) | |||
Other income | 106 | 15 | 15 | |||
Other expense | (216) | (87) | (121) | |||
Financial interest on debt | (140) | (171) | (204) | |||
Financial income from marketable securities & cash equivalents | 40 | 55 | 113 | |||
Cost of net debt | (100) | (116) | (91) | |||
Other financial income | 240 | 159 | 229 | |||
Other financial expense | (82) | (81) | (80) | |||
Equity in income (loss) of affiliates | 393 | 467 | 538 | |||
Income taxes | (1,877) | (1,902) | (4,931) | |||
Consolidated net income | 2,223 | 2,324 | 4,875 | |||
Group share* | 2,169 | 2,290 | 4,732 | |||
Minority interests | 54 | 34 | 143 | |||
Earnings per share (€) | 0,97 | 1,03 | 2,12 | |||
Fully-diluted earnings per share (€)** | 0,97 | 1,02 | 2,10 | |||
 |  |  |  | |||
* Adjusted net income | 1,721 | 2,113 | 3,723 | |||
** Adjusted fully-diluted earnings per share (€) | 0,77 | 0,95 | 1,65 | |||
(a) Except for per share amounts. |
CONSOLIDATED STATEMENT OF INCOME | Â | Â | ||
TOTAL | ||||
(unaudited) | ||||
 | ||||
(M€) (a) |
1st half
2009 |
1st half
2008 |
||
Sales | 61,471 | 92,413 | ||
Excise taxes | (9,429) | (9,826) | ||
Revenues from sales | 52,042 | 82,587 | ||
Purchases, net of inventory variation | (31,528) | (53,577) | ||
Other operating expenses | (9,399) | (9,271) | ||
Exploration costs | (331) | (393) | ||
Depreciation, depletion and amortization of tangible assets and mineral interests | (3,156) | (2,678) | ||
Other income | 121 | 168 | ||
Other expense | (303) | (169) | ||
Financial interest on debt | (311) | (461) | ||
Financial income from marketable securities & cash equivalents | 95 | 242 | ||
Cost of net debt | (216) | (219) | ||
Other financial income | 399 | 345 | ||
Other financial expense | (163) | (151) | ||
Equity in income (loss) of affiliates | 860 | 1,084 | ||
Income taxes | (3,779) | (9,148) | ||
Consolidated net income | 4,547 | 8,578 | ||
Group share* | 4,459 | 8,334 | ||
Minority interests | 88 | 244 | ||
Earnings per share (€) | 2,00 | 3,72 | ||
Fully-diluted earnings per share (€)** | 1,99 | 3,70 | ||
 |  |  | ||
* Adjusted net income | 3,834 | 6,977 | ||
** Adjusted fully-diluted earnings per share (€) | 1,72 | 3,10 | ||
(a) Except for per share amounts. |
CONSOLIDATED BALANCE SHEET | Â | Â | Â | Â | ||||
TOTAL | ||||||||
 | ||||||||
 | ||||||||
(M€) |
June 30, 2009
(unaudited) |
March 31, 2009
(unaudited) |
December 31, 2008 |
June 30, 2008
(unaudited) |
||||
ASSETS | ||||||||
Non-current assets | ||||||||
Intangible assets, net | 5,955 | 5,904 | 5,341 | 4,381 | ||||
Property, plant and equipment, net | 48,762 | 48,773 | 46,142 | 41,756 | ||||
Equity affiliates : investments and loans | 14,075 | 15,093 | 14,668 | 14,524 | ||||
Other investments | 1,211 | 1,192 | 1,165 | 1,246 | ||||
Hedging instruments of non-current financial debt | 875 | 934 | 892 | 540 | ||||
Other non-current assets | 3,095 | 3,244 | 3,044 | 2,179 | ||||
Total non-current assets | 73,973 | 75,140 | 71,252 | 64,626 | ||||
Current assets | ||||||||
Inventories, net | 11,749 | 10,097 | 9,621 | 17,185 | ||||
Accounts receivable, net | 15,226 | 14,940 | 15,287 | 21,856 | ||||
Other current assets | 9,253 | 9,047 | 9,642 | 9,644 | ||||
Current financial assets | 217 | 150 | 187 | 223 | ||||
Cash and cash equivalents | 14,299 | 13,319 | 12,321 | 7,245 | ||||
Total current assets | 50,744 | 47,553 | 47,058 | 56,153 | ||||
Total assets | 124,717 | 122,693 | 118,310 | 120,779 | ||||
LIABILITIES & SHAREHOLDERS' EQUITY | ||||||||
Shareholders' equity | ||||||||
Common shares | 5,931 | 5,931 | 5,930 | 6,003 | ||||
Paid-in surplus and retained earnings | 55,031 | 55,198 | 52,947 | 55,024 | ||||
Currency translation adjustment | (4,656) | (3,523) | (4,876) | (6,483) | ||||
Treasury shares | (5,007) | (5,009) | (5,009) | (6,271) | ||||
Total shareholders' equity - Group Share | 51,299 | 52,597 | 48,992 | 48,273 | ||||
Minority interests | 963 | 1,004 | 958 | 855 | ||||
Total shareholders' equity | 52,262 | 53,601 | 49,950 | 49,128 | ||||
Non-current liabilities | ||||||||
Deferred income taxes | 8,561 | 8,478 | 7,973 | 7,748 | ||||
Employee benefits | 2,006 | 2,035 | 2,011 | 2,533 | ||||
Provisions and other non-current liabilities | 8,087 | 8,391 | 7,858 | 6,567 | ||||
Total non-current liabilities | 18,654 | 18,904 | 17,842 | 16,848 | ||||
Non-current financial debt | 19,640 | 19,078 | 16,191 | 14,777 | ||||
Current liabilities | ||||||||
Accounts payable | 14,036 | 13,894 | 14,815 | 19,297 | ||||
Other creditors and accrued liabilities | 12,115 | 12,375 | 11,632 | 15,760 | ||||
Current borrowings | 7,916 | 4,771 | 7,722 | 4,795 | ||||
Other current financial liabilities | 94 | 70 | 158 | 174 | ||||
Total current liabilities | 34,161 | 31,110 | 34,327 | 40,026 | ||||
Total Liabilities and shareholders' equity | 124,717 | 122,693 | 118,310 | 120,779 |
CONSOLIDATED STATEMENT OF CASH FLOW | Â | Â | Â | |||
TOTAL | ||||||
(unaudited) | ||||||
 | ||||||
(M€) |
2nd quarter
2009 |
1st quarter
2009 |
2nd quarter
2008 |
|||
CASH FLOW FROM OPERATING ACTIVITIES | ||||||
Consolidated net income | 2,223 | 2,324 | 4,875 | |||
Depreciation, depletion and amortization | 1,712 | 1,661 | 1,482 | |||
Non-current liabilities, valuation allowances and deferred taxes | 281 | (68) | 32 | |||
Impact of coverage of pension benefit plans | - | - | - | |||
(Gains) losses on sales of assets | (31) | (15) | (15) | |||
Undistributed affiliates' equity earnings | 81 | (79) | 104 | |||
(Increase) decrease in working capital | (2,363) | 145 | (4,563) | |||
Other changes, net | 36 | 26 | 7 | |||
Cash flow from operating activities | 1,939 | 3,994 | 1,922 | |||
CASH FLOW USED IN INVESTING ACTIVITIES | ||||||
Intangible assets and property, plant and equipment additions | (3,312) | (2,484) | (2,619) | |||
Acquisitions of subsidiaries, net of cash acquired | (109) | (47) | - | |||
Investments in equity affiliates and other securities | (131) | (84) | (41) | |||
Increase in non-current loans | (82) | (320) | (208) | |||
Total expenditures | (3,634) | (2,935) | (2,868) | |||
Proceeds from disposal of intangible assets and property, plant and equipment | 55 | 60 | 16 | |||
Proceeds from disposal of subsidiaries, net of cash sold | - | - | 84 | |||
Proceeds from disposal of non-current investments | 726 | 299 | 20 | |||
Repayment of non-current loans | 77 | 113 | 606 | |||
Total divestments | 858 | 472 | 726 | |||
Cash flow used in investing activities | (2,776) | (2,463) | (2,142) | |||
CASH FLOW (FROM)/USED FINANCING ACTIVITIES | ||||||
Issuance (repayment) of shares: | ||||||
- Parent company shareholders | 5 | 9 | 233 | |||
- Treasury shares | 2 | - | (284) | |||
- Minority shareholders | - | - | - | |||
Cash dividends paid: | ||||||
- Parent company shareholders | (2,541) | - | (2,404) | |||
- Minority shareholders | (141) | (4) | (127) | |||
Net issuance (repayment) of non-current debt | 2,010 | 2,844 | 1,562 | |||
Increase (decrease) in current borrowings | 2,350 | (3,417) | 55 | |||
Increase (decrease) in current financial assets and liabilities | - | - | (18) | |||
Cash flow (from) / used financing activities | 1,685 | (568) | (983) | |||
Net increase (decrease) in cash and cash equivalents | 848 | 963 | (1,203) | |||
Effect of exchange rates | 132 | 35 | 107 | |||
Cash and cash equivalents at the beginning of the period | 13,319 | 12,321 | 8,341 | |||
Cash and cash equivalents at the end of the period | 14,299 | 13,319 | 7,245 |
CONSOLIDATED STATEMENT OF CASH FLOW | Â | Â | ||
TOTAL | ||||
(unaudited) | ||||
 | ||||
(M€) |
1st half
2009 |
1st half
2008 |
||
CASH FLOW FROM OPERATING ACTIVITIES | ||||
Consolidated net income | 4,547 | 8,578 | ||
Depreciation, depletion and amortization | 3,373 | 2,887 | ||
Non-current liabilities, valuation allowances and deferred taxes | 213 | 43 | ||
Impact of coverage of pension benefit plans | - | - | ||
(Gains) losses on sales of assets | (46) | (168) | ||
Undistributed affiliates' equity earnings | 2 | (198) | ||
(Increase) decrease in working capital | (2,218) | (3,953) | ||
Other changes, net | 62 | 49 | ||
Cash flow from operating activities | 5,933 | 7,238 | ||
CASH FLOW USED IN INVESTING ACTIVITIES | ||||
Intangible assets and property, plant and equipment additions | (5,796) | (4,946) | ||
Acquisitions of subsidiaries, net of cash acquired | (156) | - | ||
Investments in equity affiliates and other securities | (215) | (148) | ||
Increase in non-current loans | (402) | (417) | ||
Total expenditures | (6,569) | (5,511) | ||
Proceeds from disposal of intangible assets and property, plant and equipment | 115 | 22 | ||
Proceeds from disposal of subsidiaries, net of cash sold | - | 84 | ||
Proceeds from disposal of non-current investments | 1,025 | 89 | ||
Repayment of non-current loans | 190 | 729 | ||
Total divestments | 1,330 | 924 | ||
Cash flow used in investing activities | (5,239) | (4,587) | ||
CASH FLOW (FROM)/USED FINANCING ACTIVITIES | ||||
Issuance (repayment) of shares: | ||||
- Parent company shareholders | 14 | 242 | ||
- Treasury shares | 2 | (711) | ||
- Minority shareholders | - | (9) | ||
Cash dividends paid: | ||||
- Parent company shareholders | (2,541) | (2,404) | ||
- Minority shareholders | (145) | (128) | ||
Net issuance (repayment) of non-current debt | 4,854 | 2,065 | ||
Increase (decrease) in current borrowings | (1,067) | (832) | ||
Increase (decrease) in current financial assets and liabilities | - | 817 | ||
Cash flow (from) / used financing activities | 1,117 | (960) | ||
Net increase (decrease) in cash and cash equivalents | 1,811 | 1,691 | ||
Effect of exchange rates | 167 | (434) | ||
Cash and cash equivalents at the beginning of the period | 12,321 | 5,988 | ||
Cash and cash equivalents at the end of the period | 14,299 | 7,245 |
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY | Â | Â | Â | Â | |||||||||||||
TOTAL | Â | Â | Â | Â | |||||||||||||
(unaudited) | Â | Â | Â | Â | Â | Â | Â | Â | Â | ||||||||
Common shares issued | Paid-in surplus and retained earnings | Currency translation adjustment | Treasury shares | Shareholders' equity Group Share | Minority interests | Total shareholders' equity | |||||||||||
(M€) | Number | Amount |  |  | Number | Amount |  |  |  | ||||||||
As of January 1, 2008 | 2,395,532,097 | 5,989 | 48,797 | (4,396) | (151,421,232) | (5,532) | 44,858 | 842 | 45,700 | ||||||||
Net income for the first half | - | - | 8,334 | - | - | - | 8,334 | 244 | 8,578 | ||||||||
Other comprehensive Income | - | - | (43) | (2,087) | - | - | (2,130) | (103) | (2,233) | ||||||||
Comprehensive Income | - | - | 8,291 | (2,087) | - | - | 6,204 | 141 | 6,345 | ||||||||
Dividend | - | - | (2,404) | - | - | - | (2,404) | (128) | (2,532) | ||||||||
Issuance of common shares | 5,678,338 | 14 | 228 | - | - | - | 242 | - | 242 | ||||||||
Purchase of treasury shares | - | - | - | - | (16,000,000) | (818) | (818) | - | (818) | ||||||||
Sale of treasury shares (1) | - | - | 28 | - | 2,679,805 | 79 | 107 | - | 107 | ||||||||
Share-based payments | - | - | 84 | - | - | - | 84 | - | 84 | ||||||||
Other operations with minority interests | - | - | - | - | - | - | - | - | - | ||||||||
Share cancellation | - | - | - | - | - | - | - | - | - | ||||||||
Transactions with shareholders | 5,678,338 | 14 | (2,064) | - | (13,320,195) | (739) | (2,789) | (128) | (2,917) | ||||||||
As of June 30, 2008 | 2,401,210,435 | 6,003 | 55,024 | (6,483) | (164,741,427) | (6,271) | 48,273 | 855 | 49,128 | ||||||||
Net income for the second half | - | - | 2,256 | - | - | - | 2,256 | 119 | 2,375 | ||||||||
Other comprehensive Income | - | - | (215) | 1,607 | - | - | 1,392 | 69 | 1,461 | ||||||||
Comprehensive Income | - | - | 2,041 | 1,607 | - | - | 3,648 | 188 | 3,836 | ||||||||
Dividend | - | - | (2,541) | - | - | - | (2,541) | (85) | (2,626) | ||||||||
Issuance of common shares | 597,639 | 2 | 18 | - | - | - | 20 | - | 20 | ||||||||
Purchase of treasury shares | - | - | - | - | (11,600,000) | (521) | (521) | - | (521) | ||||||||
Sale of treasury shares (1) | - | - | (99) | - | 3,259,332 | 142 | 43 | - | 43 | ||||||||
Share-based payments | - | - | 70 | - | - | - | 70 | - | 70 | ||||||||
Other operations with minority interests | - | - | - | - | - | - | - | - | - | ||||||||
Share cancellation | (30,000,000) | (75) | (1,566) | - | 30,000,000 | 1,641 | - | - | - | ||||||||
Transactions with shareholders | (29,402,361) | (73) | (4,118) | - | 21,659,332 | 1,262 | (2,929) | (85) | (3,014) | ||||||||
As of December 31, 2008 | 2,371,808,074 | 5,930 | 52,947 | (4,876) | (143,082,095) | (5,009) | 48,992 | 958 | 49,950 | ||||||||
Net income for the first half | - | - | 4,459 | - | - | - | 4,459 | 88 | 4,547 | ||||||||
Other comprehensive Income | - | - | 96 | 220 | - | - | 316 | 86 | 402 | ||||||||
Comprehensive Income | - | - | 4,555 | 220 | - | - | 4,775 | 174 | 4,949 | ||||||||
Dividend | - | - | (2,541) | - | - | - | (2,541) | (145) | (2,686) | ||||||||
Issuance of common shares | 565,886 | 1 | 13 | - | - | - | 14 | - | 14 | ||||||||
Purchase of treasury shares | - | - | - | - | - | - | - | - | - | ||||||||
Sale of treasury shares (1) | - | - | - | - | 51,995 | 2 | 2 | - | 2 | ||||||||
Share-based payments | - | - | 80 | - | - | - | 80 | - | 80 | ||||||||
Other operations with minority interests | - | - | (23) | - | - | - | (23) | (24) | (47) | ||||||||
Share cancellation | - | - | - | - | - | - | - | - | - | ||||||||
Transactions with shareholders | 565,886 | 1 | (2,471) | - | 51,995 | 2 | (2,468) | (169) | (2,637) | ||||||||
As of June 30, 2009 | 2,372,373,960 | 5,931 | 55,031 | (4,656) | (143,030,100) | (5,007) | 51,299 | 963 | 52,262 |
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (a) | Â | |||
TOTAL | Â | |||
(unaudited) | ||||
 | ||||
(M€) |
1st half
2009 |
1st half
2008 |
||
Net income | 4,547 | 8,578 | ||
Other comprehensive income | ||||
Currency translation adjustment | 246 | (1,927) | ||
Available for sale financial assets | 39 | (43) | ||
Cash flow hedge | 58 | - | ||
Share of other comprehensive income of associates, net amount | 93 | (270) | ||
Other | (11) | (1) | ||
 | ||||
Tax effect | (23) | 8 | ||
Total other comprehensive income (net amount) | 402 | (2,233) | ||
 |  |  | ||
Comprehensive income | 4,949 | 6,345 | ||
- Group share | 4,775 | 6,204 | ||
- Minority interests | 174 | 141 | ||
 | ||||
(a) In accordance with revised IAS 1, applicable from January 1, 2009. |
BUSINESS SEGMENT INFORMATION | Â | Â | Â | Â | Â | Â | ||||||
TOTAL | ||||||||||||
(unaudited) | ||||||||||||
 |  |  |  |  |  |  | ||||||
1st half 2009
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 7,874 | 46,686 | 6,902 | 9 | - | 61,471 | ||||||
Intersegment sales | 7,349 | 1,646 | 276 | 79 | (9,350) | - | ||||||
Excise taxes | - | (9,429) | - | - | - | (9,429) | ||||||
Revenues from sales | 15,223 | 38,903 | 7,178 | 88 | (9,350) | 52,042 | ||||||
Operating expenses | (7,367) | (36,253) | (6,635) | (353) | 9,350 | (41,258) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (2,121) | (683) | (335) | (17) | - | (3,156) | ||||||
Operating income | 5,735 | 1,967 | 208 | (282) | - | 7,628 | ||||||
Equity in income (loss) of affiliates and other items | 572 | 127 | (121) | 336 | - | 914 | ||||||
Tax on net operating income | (3,413) | (581) | 1 | 143 | - | (3,850) | ||||||
Net operating income | 2,894 | 1,513 | 88 | 197 | - | 4,692 | ||||||
Net cost of net debt | (145) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (88) | ||||||
Net income | 4,459 | |||||||||||
 |  |  |  |  |  |  | ||||||
1st half 2009 (adjustments) (a)
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | ||||||||||||
Intersegment sales | ||||||||||||
Excise taxes | Â | Â | Â | Â | Â | Â | ||||||
Revenues from sales | ||||||||||||
Operating expenses | - | 1,097 | 259 | - | 1,356 | |||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | - | (62) | (43) | - | Â | (105) | ||||||
Operating income (b) | - | 1,035 | 216 | - | 1,251 | |||||||
Equity in income (loss) of affiliates and other items (c) | (39) | 63 | (138) | (141) | (255) | |||||||
Tax on net operating income | - | (341) | (29) | - | Â | (370) | ||||||
Net operating income (b) | (39) | 757 | 49 | (141) | 626 | |||||||
Net cost of net debt | - | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (1) | ||||||
Net income | 625 | |||||||||||
(a) Adjustments include special items, inventory valuation effect
and equity share of adjustments and selected items related to
Sanofi-Aventis
 (b) Of which inventory valuation effect |
 |
 |
 |
 |
 |
 |
||||||
On operating income | - | 1,278 | 264 | - | ||||||||
On net operating income | - | 945 | 171 | - | ||||||||
(c) Of which equity share of adjustments and selected items related to Sanofi-Aventis | - | - | - | (182) | Â | Â | ||||||
1st half 2009 (adjusted)
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 7,874 | 46,686 | 6,902 | 9 | - | 61,471 | ||||||
Intersegment sales | 7,349 | 1,646 | 276 | 79 | (9,350) | - | ||||||
Excise taxes | - | (9,429) | - | - | - | (9,429) | ||||||
Revenues from sales | 15,223 | 38,903 | 7,178 | 88 | (9,350) | 52,042 | ||||||
Operating expenses | (7,367) | (37,350) | (6,894) | (353) | 9,350 | (42,614) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (2,121) | (621) | (292) | (17) | - | (3,051) | ||||||
Adjusted operating income | 5,735 | 932 | (8) | (282) | - | 6,377 | ||||||
Equity in income (loss) of affiliates and other items | 611 | 64 | 17 | 477 | - | 1,169 | ||||||
Tax on net operating income | (3,413) | (240) | 30 | 143 | - | (3,480) | ||||||
Adjusted net operating income | 2,933 | 756 | 39 | 338 | - | 4,066 | ||||||
Net cost of net debt | (145) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (87) | ||||||
Ajusted net income | 3,834 | |||||||||||
 |  |  |  |  |  |  | ||||||
1st half 2009
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Total expenditures | 4,914 | 1,320 | 294 | 41 | 6,569 | |||||||
Total divestments | 234 | 62 | 14 | 1,020 | 1,330 | |||||||
Cash flow from operating activities | 4,521 | 1,620 | 458 | (666) | Â | 5,933 |
BUSINESS SEGMENT INFORMATION | Â | Â | Â | Â | Â | Â | ||||||
TOTAL | ||||||||||||
(unaudited) | ||||||||||||
 |  |  |  |  |  |  | ||||||
2nd quarter 2009
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 3,427 | 24,318 | 3,684 | 1 | - | 31,430 | ||||||
Intersegment sales | 4,107 | 1,005 | 152 | 42 | (5,306) | - | ||||||
Excise taxes | - | (4,856) | - | - | - | (4,856) | ||||||
Revenues from sales | 7,534 | 20,467 | 3,836 | 43 | (5,306) | 26,574 | ||||||
Operating expenses | (3,635) | (19,154) | (3,498) | (198) | 5,306 | (21,179) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,056) | (382) | (191) | (7) | - | (1,636) | ||||||
Operating income | 2,843 | 931 | 147 | (162) | - | 3,759 | ||||||
Equity in income (loss) of affiliates and other items | 329 | 85 | (117) | 144 | - | 441 | ||||||
Tax on net operating income | (1,739) | (278) | 18 | 81 | - | (1,918) | ||||||
Net operating income | 1,433 | 738 | 48 | 63 | - | 2,282 | ||||||
Net cost of net debt | (59) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (54) | ||||||
Net income | 2,169 | |||||||||||
 |  |  |  |  |  |  | ||||||
2nd quarter 2009 (adjustments) (a)
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | ||||||||||||
Intersegment sales | ||||||||||||
Excise taxes | Â | Â | Â | Â | Â | Â | ||||||
Revenues from sales | ||||||||||||
Operating expenses | - | 852 | 130 | - | 982 | |||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | - | (62) | (43) | - | Â | (105) | ||||||
Operating income (b) | - | 790 | 87 | - | 877 | |||||||
Equity in income (loss) of affiliates and other items (c) | (18) | 48 | (119) | (91) | (180) | |||||||
Tax on net operating income | - | (256) | 9 | - | Â | (247) | ||||||
Net operating income (b) | (18) | 582 | (23) | (91) | 450 | |||||||
Net cost of net debt | - | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (2) | ||||||
Net income | 448 | |||||||||||
(a) Adjustments include special items, inventory valuation effect
and equity share of adjustments and selected items related to
Sanofi-Aventis
 (b) Of which inventory valuation effect |
 |
 |
 |
 |
 |
 |
||||||
On operating income | - | 933 | 132 | - | ||||||||
On net operating income | - | 699 | 91 | - | ||||||||
(c) Of which equity share of adjustments and selected items related to Sanofi-Aventis | - | - | - | (119) | Â | Â | ||||||
2nd quarter 2009 (adjusted)
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 3,427 | 24,318 | 3,684 | 1 | - | 31,430 | ||||||
Intersegment sales | 4,107 | 1,005 | 152 | 42 | (5,306) | - | ||||||
Excise taxes | - | (4,856) | - | - | - | (4,856) | ||||||
Revenues from sales | 7,534 | 20,467 | 3,836 | 43 | (5,306) | 26,574 | ||||||
Operating expenses | (3,635) | (20,006) | (3,628) | (198) | 5,306 | (22,161) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,056) | (320) | (148) | (7) | - | (1,531) | ||||||
Adjusted operating income | 2,843 | 141 | 60 | (162) | - | 2,882 | ||||||
Equity in income (loss) of affiliates and other items | 347 | 37 | 2 | 235 | - | 621 | ||||||
Tax on net operating income | (1,739) | (22) | 9 | 81 | - | (1,671) | ||||||
Adjusted net operating income | 1,451 | 156 | 71 | 154 | - | 1,832 | ||||||
Net cost of net debt | (59) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (52) | ||||||
Ajusted net income | 1,721 | |||||||||||
 |  |  |  |  |  |  | ||||||
2nd quarter 2009
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Total expenditures | 2,664 | 825 | 115 | 30 | 3,634 | |||||||
Total divestments | 105 | 26 | 8 | 719 | 858 | |||||||
Cash flow from operating activities | 1,943 | (28) | 280 | (256) | Â | 1,939 |
BUSINESS SEGMENT INFORMATION | Â | Â | Â | Â | Â | Â | ||||||
TOTAL | ||||||||||||
(unaudited) | ||||||||||||
 |  |  |  |  |  |  | ||||||
1st quarter 2009
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 4,447 | 22,368 | 3,218 | 8 | - | 30,041 | ||||||
Intersegment sales | 3,242 | 641 | 124 | 37 | (4,044) | - | ||||||
Excise taxes | - | (4,573) | - | - | - | (4,573) | ||||||
Revenues from sales | 7,689 | 18,436 | 3,342 | 45 | (4,044) | 25,468 | ||||||
Operating expenses | (3,732) | (17,099) | (3,137) | (155) | 4,044 | (20,079) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,065) | (301) | (144) | (10) | - | (1,520) | ||||||
Operating income | 2,892 | 1,036 | 61 | (120) | - | 3,869 | ||||||
Equity in income (loss) of affiliates and other items | 243 | 42 | (4) | 192 | - | 473 | ||||||
Tax on net operating income | (1,674) | (303) | (17) | 62 | - | (1,932) | ||||||
Net operating income | 1,461 | 775 | 40 | 134 | - | 2,410 | ||||||
Net cost of net debt | (86) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (34) | ||||||
Net income | 2,290 | |||||||||||
 |  |  |  |  |  |  | ||||||
1st quarter 2009 (adjustments)
(a)
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | ||||||||||||
Intersegment sales | ||||||||||||
Excise taxes | Â | Â | Â | Â | Â | Â | ||||||
Revenues from sales | ||||||||||||
Operating expenses | - | 245 | 129 | - | 374 | |||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | - | - | - | - | Â | - | ||||||
Operating income (b) | - | 245 | 129 | - | 374 | |||||||
Equity in income (loss) of affiliates and other items (c) | (21) | 15 | (19) | (50) | (75) | |||||||
Tax on net operating income | - | (85) | (38) | - | Â | (123) | ||||||
Net operating income (b) | (21) | 175 | 72 | (50) | 176 | |||||||
Net cost of net debt | - | |||||||||||
Minority interests | Â | Â | Â | Â | Â | 1 | ||||||
Net income | 177 | |||||||||||
(a) Adjustments include special items, inventory valuation effect
and equity share of adjustments and selected items related to
Sanofi-Aventis
 (b) Of which inventory valuation effect |
 |
 |
 |
 |
 |
 |
||||||
On operating income | - | 345 | 132 | - | ||||||||
On net operating income | - | 246 | 80 | - | ||||||||
(c) Of which equity share of adjustments and selected items related to Sanofi-Aventis | - | - | - | (63) | Â | Â | ||||||
1st quarter 2009 (adjusted)
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 4,447 | 22,368 | 3,218 | 8 | - | 30,041 | ||||||
Intersegment sales | 3,242 | 641 | 124 | 37 | (4,044) | - | ||||||
Excise taxes | - | (4,573) | - | - | - | (4,573) | ||||||
Revenues from sales | 7,689 | 18,436 | 3,342 | 45 | (4,044) | 25,468 | ||||||
Operating expenses | (3,732) | (17,344) | (3,266) | (155) | 4,044 | (20,453) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,065) | (301) | (144) | (10) | - | (1,520) | ||||||
Adjusted operating income | 2,892 | 791 | (68) | (120) | - | 3,495 | ||||||
Equity in income (loss) of affiliates and other items | 264 | 27 | 15 | 242 | - | 548 | ||||||
Tax on net operating income | (1,674) | (218) | 21 | 62 | - | (1,809) | ||||||
Adjusted net operating income | 1,482 | 600 | (32) | 184 | - | 2,234 | ||||||
Net cost of net debt | (86) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (35) | ||||||
Ajusted net income | 2,113 | |||||||||||
 |  |  |  |  |  |  | ||||||
1st quarter 2009
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Total expenditures | 2,250 | 495 | 179 | 11 | 2,935 | |||||||
Total divestments | 129 | 36 | 6 | 301 | 472 | |||||||
Cash flow from operating activities | 2,578 | 1,648 | 178 | (410) | Â | 3,994 |
BUSINESS SEGMENT INFORMATION | Â | Â | Â | Â | Â | Â | ||||||
TOTAL | ||||||||||||
(unaudited) | ||||||||||||
 |  |  |  |  |  |  | ||||||
1st half 2008
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 11,935 | 69,770 | 10,707 | 1 | - | 92,413 | ||||||
Intersegment sales | 13,980 | 3,050 | 706 | 70 | (17,806) | - | ||||||
Excise taxes | - | (9,826) | - | - | - | (9,826) | ||||||
Revenues from sales | 25,915 | 62,994 | 11,413 | 71 | (17,806) | 82,587 | ||||||
Operating expenses | (10,697) | (59,346) | (10,648) | (356) | 17,806 | (63,241) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,831) | (576) | (257) | (14) | - | (2,678) | ||||||
Operating income | 13,387 | 3,072 | 508 | (299) | - | 16,668 | ||||||
Equity in income (loss) of affiliates and other items | 904 | (13) | 3 | 383 | - | 1,277 | ||||||
Tax on net operating income | (8,331) | (898) | (143) | 150 | - | (9,222) | ||||||
Net operating income | 5,960 | 2,161 | 368 | 234 | - | 8,723 | ||||||
Net cost of net debt | (145) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (244) | ||||||
Net income | 8,334 | |||||||||||
 |  |  |  |  |  |  | ||||||
1st half 2008 (adjustments) (a)
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | ||||||||||||
Intersegment sales | ||||||||||||
Excise taxes | Â | Â | Â | Â | Â | Â | ||||||
Revenues from sales | ||||||||||||
Operating expenses | - | 1,830 | 232 | - | 2,062 | |||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | - | - | - | - | Â | - | ||||||
Operating income (b) | - | 1,830 | 232 | - | 2,062 | |||||||
Equity in income (loss) of affiliates and other items (c) | 130 | 15 | (22) | (152) | (29) | |||||||
Tax on net operating income | - | (582) | (70) | - | Â | (652) | ||||||
Net operating income (b) | 130 | 1,263 | 140 | (152) | 1,381 | |||||||
Net cost of net debt | - | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (24) | ||||||
Net income | 1,357 | |||||||||||
(a) Adjustments include special items, inventory valuation effect
and equity share of adjustments related to Sanofi-Aventis
 (b) Of which inventory valuation effect |
||||||||||||
On operating income | - | 1,830 | 232 | - | ||||||||
On net operating income | - | 1,298 | 154 | - | ||||||||
(c) Of which equity share of adjustments related to Sanofi-Aventis | - | - | - | (149) | Â | Â | ||||||
1st half 2008 (adjusted)
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 11,935 | 69,770 | 10,707 | 1 | - | 92,413 | ||||||
Intersegment sales | 13,980 | 3,050 | 706 | 70 | (17,806) | - | ||||||
Excise taxes | - | (9,826) | - | - | - | (9,826) | ||||||
Revenues from sales | 25,915 | 62,994 | 11,413 | 71 | (17,806) | 82,587 | ||||||
Operating expenses | (10,697) | (61,176) | (10,880) | (356) | 17,806 | (65,303) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,831) | (576) | (257) | (14) | - | (2,678) | ||||||
Adjusted operating income | 13,387 | 1,242 | 276 | (299) | - | 14,606 | ||||||
Equity in income (loss) of affiliates and other items | 774 | (28) | 25 | 535 | - | 1,306 | ||||||
Tax on net operating income | (8,331) | (316) | (73) | 150 | - | (8,570) | ||||||
Adjusted net operating income | 5,830 | 898 | 228 | 386 | - | 7,342 | ||||||
Net cost of net debt | (145) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (220) | ||||||
Ajusted net income | 6,977 | |||||||||||
 |  |  |  |  |  |  | ||||||
1st half 2008
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Total expenditures | 4,254 | 808 | 385 | 64 | 5,511 | |||||||
Total divestments | 672 | 152 | 19 | 81 | 924 | |||||||
Cash flow from operating activities | 7,894 | (223) | (33) | (400) | Â | 7,238 |
BUSINESS SEGMENT INFORMATION | Â | Â | Â | Â | Â | Â | ||||||
TOTAL | ||||||||||||
(unaudited) | ||||||||||||
 |  |  |  |  |  |  | ||||||
2nd quarter 2008
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 5,739 | 36,990 | 5,478 | (7) | - | 48,200 | ||||||
Intersegment sales | 7,862 | 1,497 | 449 | 37 | (9,845) | - | ||||||
Excise taxes | - | (4,900) | - | - | - | (4,900) | ||||||
Revenues from sales | 13,601 | 33,587 | 5,927 | 30 | (9,845) | 43,300 | ||||||
Operating expenses | (5,679) | (31,095) | (5,491) | (180) | 9,845 | (32,600) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (958) | (291) | (128) | (7) | - | (1,384) | ||||||
Operating income | 6,964 | 2,201 | 308 | (157) | - | 9,316 | ||||||
Equity in income (loss) of affiliates and other items | 439 | 20 | (11) | 133 | - | 581 | ||||||
Tax on net operating income | (4,304) | (651) | (88) | 78 | - | (4,965) | ||||||
Net operating income | 3,099 | 1,570 | 209 | 54 | - | 4,932 | ||||||
Net cost of net debt | (57) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (143) | ||||||
Net income | 4,732 | |||||||||||
 |  |  |  |  |  |  | ||||||
2nd quarter 2008 (adjustments) (a)
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | ||||||||||||
Intersegment sales | ||||||||||||
Excise taxes | Â | Â | Â | Â | Â | Â | ||||||
Revenues from sales | ||||||||||||
Operating expenses | - | 1,457 | 230 | - | 1,687 | |||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | - | - | - | - | Â | - | ||||||
Operating income (b) | - | 1,457 | 230 | - | 1,687 | |||||||
Equity in income (loss) of affiliates and other items (c) | - | (10) | (22) | (96) | (128) | |||||||
Tax on net operating income | - | (464) | (69) | - | Â | (533) | ||||||
Net operating income (b) | - | 983 | 139 | (96) | 1,026 | |||||||
Net cost of net debt | - | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (17) | ||||||
Net income | 1,009 | |||||||||||
(a) Adjustments include special items, inventory valuation effect and equity share of adjustments related to Sanofi-Aventis  (b) Of which inventory valuation effect |
||||||||||||
On operating income | - | 1,457 | 230 | - | ||||||||
On net operating income | - | 1,018 | 153 | - | ||||||||
(c) Of which equity share of adjustments related to Sanofi-Aventis | - | - | - | (78) | Â | Â | ||||||
2nd quarter 2008 (adjusted)
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 5,739 | 36,990 | 5,478 | (7) | - | 48,200 | ||||||
Intersegment sales | 7,862 | 1,497 | 449 | 37 | (9,845) | - | ||||||
Excise taxes | - | (4,900) | - | - | - | (4,900) | ||||||
Revenues from sales | 13,601 | 33,587 | 5,927 | 30 | (9,845) | 43,300 | ||||||
Operating expenses | (5,679) | (32,552) | (5,721) | (180) | 9,845 | (34,287) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (958) | (291) | (128) | (7) | - | (1,384) | ||||||
Adjusted operating income | 6,964 | 744 | 78 | (157) | - | 7,629 | ||||||
Equity in income (loss) of affiliates and other items | 439 | 30 | 11 | 229 | - | 709 | ||||||
Tax on net operating income | (4,304) | (187) | (19) | 78 | - | (4,432) | ||||||
Adjusted net operating income | 3,099 | 587 | 70 | 150 | - | 3,906 | ||||||
Net cost of net debt | (57) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (126) | ||||||
Ajusted net income | 3,723 | |||||||||||
 |  |  |  |  |  |  | ||||||
2nd quarter 2008
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Total expenditures | 2,076 | 514 | 221 | 57 | 2,868 | |||||||
Total divestments | 565 | 128 | 12 | 21 | 726 | |||||||
Cash flow from operating activities | 3,643 | (1,391) | 169 | (499) | Â | 1,922 |
CONSOLIDATED STATEMENT OF INCOME (Impact of adjustments) | Â | Â | ||||
TOTAL | Â | |||||
(unaudited) | ||||||
 |  |  | ||||
2nd quarter 2009
(M€) |
Adjusted | Adjustments | Consolidated statement of income | |||
Sales | 31,430 | - | 31,430 | |||
Excise taxes | (4,856) | - | (4,856) | |||
Revenues from sales | 26,574 | - | 26,574 | |||
Purchases net of inventory variation | (17,365) | 1,065 | (16,300) | |||
Other operating expenses | (4,641) | (83) | (4,724) | |||
Exploration costs | (155) | - | (155) | |||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,531) | (105) | (1,636) | |||
Other income | 78 | 28 | 106 | |||
Other expense | (56) | (160) | (216) | |||
Financial interest on debt | (140) | - | (140) | |||
Financial income from marketable securities & cash equivalents | 40 | - | 40 | |||
Cost of net debt | (100) | - | (100) | |||
Other financial income | 240 | - | 240 | |||
Other financial expense | (82) | - | (82) | |||
Equity in income (loss) of affiliates | 441 | (48) | 393 | |||
Income taxes | (1,630) | (247) | (1,877) | |||
Consolidated net income | 1,773 | 450 | 2,223 | |||
Group share | 1,721 | 448 | 2,169 | |||
Minority interests | 52 | 2 | 54 | |||
 | ||||||
 | ||||||
 |  |  | ||||
2nd quarter 2008
(M€) |
Adjusted | Adjustments | Consolidated statement of income | |||
Sales | 48,200 | - | 48,200 | |||
Excise taxes | (4,900) | - | (4,900) | |||
Revenues from sales | 43,300 | - | 43,300 | |||
Purchases net of inventory variation | (29,645) | 1,687 | (27,958) | |||
Other operating expenses | (4,439) | - | (4,439) | |||
Exploration costs | (203) | - | (203) | |||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,384) | - | (1,384) | |||
Other income | 13 | 2 | 15 | |||
Other expense | (26) | (95) | (121) | |||
Financial interest on debt | (204) | - | (204) | |||
Financial income from marketable securities & cash equivalents | 113 | - | 113 | |||
Cost of net debt | (91) | - | (91) | |||
Other financial income | 229 | - | 229 | |||
Other financial expense | (80) | - | (80) | |||
Equity in income (loss) of affiliates | 573 | (35) | 538 | |||
Income taxes | (4,398) | (533) | (4,931) | |||
Consolidated net income | 3,849 | 1,026 | 4,875 | |||
Group share | 3,723 | 1,009 | 4,732 | |||
Minority interests | 126 | 17 | 143 |
CONSOLIDATED STATEMENT OF INCOME (Impact of adjustments) | Â | Â | ||||
TOTAL | Â | |||||
(unaudited) | ||||||
 |  |  | ||||
1st half 2009
(M€) |
Adjusted | Adjustments | Consolidated statement of income | |||
Sales | 61,471 | - | 61,471 | |||
Excise taxes | (9,429) | - | (9,429) | |||
Revenues from sales | 52,042 | - | 52,042 | |||
Purchases net of inventory variation | (33,070) | 1,542 | (31,528) | |||
Other operating expenses | (9,213) | (186) | (9,399) | |||
Exploration costs | (331) | - | (331) | |||
Depreciation, depletion and amortization of tangible assets and mineral interests | (3,051) | (105) | (3,156) | |||
Other income | 80 | 41 | 121 | |||
Other expense | (113) | (190) | (303) | |||
Financial interest on debt | (311) | - | (311) | |||
Financial income from marketable securities & cash equivalents | 95 | - | 95 | |||
Cost of net debt | (216) | - | (216) | |||
Other financial income | 399 | - | 399 | |||
Other financial expense | (163) | - | (163) | |||
Equity in income (loss) of affiliates | 966 | (106) | 860 | |||
Income taxes | (3,409) | (370) | (3,779) | |||
Consolidated net income | 3,921 | 626 | 4,547 | |||
Group share | 3,834 | 625 | 4,459 | |||
Minority interests | 87 | 1 | 88 | |||
 | ||||||
 | ||||||
 |  |  | ||||
1st half 2008
(M€) |
Adjusted | Adjustments | Consolidated statement of income | |||
Sales | 92,413 | - | 92,413 | |||
Excise taxes | (9,826) | - | (9,826) | |||
Revenues from sales | 82,587 | - | 82,587 | |||
Purchases net of inventory variation | (55,639) | 2,062 | (53,577) | |||
Other operating expenses | (9,271) | - | (9,271) | |||
Exploration costs | (393) | - | (393) | |||
Depreciation, depletion and amortization of tangible assets and mineral interests | (2,678) | - | (2,678) | |||
Other income | 21 | 147 | 168 | |||
Other expense | (74) | (95) | (169) | |||
Financial interest on debt | (461) | - | (461) | |||
Financial income from marketable securities & cash equivalents | 242 | - | 242 | |||
Cost of net debt | (219) | - | (219) | |||
Other financial income | 345 | - | 345 | |||
Other financial expense | (151) | - | (151) | |||
Equity in income (loss) of affiliates | 1,165 | (81) | 1,084 | |||
Income taxes | (8,496) | (652) | (9,148) | |||
Consolidated net income | 7,197 | 1,381 | 8,578 | |||
Group share | 6,977 | 1,357 | 8,334 | |||
Minority interests | 220 | 24 | 244 |
1 percent changes are relative to the same period 2008.
2 dollar amounts represent euro amounts converted at the average €-$ exchange rate for the period : 1.3632 $/€ in the 2nd quarter 2009, 1.5622 $/€ in the 2nd quarter 2008, 1.3029 $/€ in the 1st quarter 2009, 1.3328 $/€ in the 1st half 2009 and 1.5304 $/€ in the 1st half 2008.
3 adjusted net income = net income using replacement cost (Group share) adjusted for special items and excluding Total’s share of adjustments and, from 2009, selected items related to Sanofi-Aventis. Total’s net income (Group share) for the 2nd quarter 2009 was 2,169 M€.
4 the ex-dividend date for the 2009 interim dividend is November 13 and the payment date is November 18, 2009; for the ADR (NYSEÂ :TOT) the ex-dividend date is November 9.
5 adjusted income (adjusted operating income, adjusted net operating income and adjusted net income) is defined as income using replacement cost, adjusted for special items affecting operating income and excluding Total’s equity share of adjustments and, from 2009, selected items related to Sanofi-Aventis; adjusted cash flow from operations is defined as cash flow from operations before changes in working capital at replacement cost; adjustment items are on page 17.
6 including acquisitions.
7 dollar amounts represent euro amounts converted at the average €-$ exchange rate for the period.
8 special items affecting operating income from the business segments had a negative impact of -188 M€ in the 2nd quarter 2009 and no impact in the 2nd quarter 2008.
9 defined as: (tax on adjusted net operating income) / (adjusted net operating income – income from equity affiliates, dividends received from investments and impairments of acquisition goodwill + tax on adjusted net operating income).
10 detail shown on page 17.
11 detail shown on page 18.
12 net investments = investments including acquisitions and net investments in equity affiliates and non-consolidated companies – asset sales + repayments by employees for loans related to stock purchase plans.
13 cash flow from operations at replacement cost before changes in working capital.
14 net cash flow = cash flow from operations + divestments – gross investments.
15 special items affecting operating income from the business segments had a negative impact of 291 M€ in the 1st half 2009 and no impact in the 1st half 2008
16 detail shown on page 17.
17 detail shown on page 18.
18 net investments = investments including acquisitions and net investments in equity affiliates and non-consolidated companies – asset sales + repayments by employees for loans related to stock purchase plans.
19 cash flow from operations at replacement cost before changes in working capital.
20 net cash flow = cash flow from operations + divestments – gross investments.
21 detail shown on page 19.
22 impact of changing hydrocarbon prices on entitlement volumes.
23 calculated based on adjusted net operating income and average capital employed, using replacement cost, as shown on page 20.
24 calculated based on adjusted net operating income and average capital employed, using replacement cost, as shown on page 20.
25 calculated based on adjusted net operating income and average capital employed, using replacement cost, as shown on page 20.
26 the ex-dividend date for the 2009 interim dividend is November 13 and the payment date is November 18, 2009; for the ADR (NYSEÂ :TOT) the ex-dividend date is November 9.
TOTAL S.A.
Capital 5Â 867Â 520Â 185, 00 euros
542 051 180 R.C.S. Nanterre
TOTAL
Bertrand DE LA NOUEBertrand DE LA NOUE
Philippe HERGAUXPhilippe HERGAUX
Sandrine
SABOUREAUSandrine
SABOUREAU
Laurent KETTENMEYERLaurent KETTENMEYER
Matthieu GOTMatthieu GOT
Tel. : 33 (1)
47 44 58 53Tel. : 33 (1)
47 44 58 53
Fax : 33 (1) 47 44 58 24Fax : 33 (1) 47 44 58 24
oror
Robert HAMMOND
(U.S.)Robert HAMMOND
(U.S.)
Tel. : (1) 713-483-5070Tel. : (1) 713-483-5070
Fax : (1) 713-483-5629Fax : (1) 713-483-5629